Bilir, Esra https://orcid.org/0000-0003-4499-6543
Ahmed, Wasim
Vidal-Alaball, Josep
Moreno Martinez, Marina
Gabriel, Boris
Gasimli, Kayal
Blau-Schneider, Bettina
Article History
Received: 27 June 2025
Accepted: 29 October 2025
First Online: 28 November 2025
Declarations
:
: The institutional review board of Newcastle University (26055/2022) granted ethical approval for this study (26055/2022).
: E Bilir: received travel and accommodation fees from GSK which is not related to this study.W Ahmed: no conflict of interest.J Vidal-Alaball: received speaker fees from Boehringer-Ingelheim which is not related to this study.M Moreno Martinez: no conflict of interest.Boris Gabriel: Honoria and expenses from INTUITIVE Surgical, Serag-Wiessner, all of them not related to this trial.Kayal Gasimli: no conflict of interest.Bettina Blau-Schneider: Honoria and expenses from INTUITIVE Surgical, PFM Medical, MSD, Seagen, all of them not related to this trial.